000739 普洛藥業
按盤價 
16.520 -1.330 (-7.451%)
16.520 -1.330 (-7.451%) | 2025/12 | 2024/12 | 2023/12 | 2022/12 | 2021/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | 13.619 | 15.907 | 17.987 | 18.713 | 20.222 |
| 總資產報酬率 ROA (%) | 7.112 | 8.088 | 8.515 | 9.391 | 11.555 |
| 投入資產回報率 ROIC (%) | 8.924 | 10.294 | 10.813 | 11.717 | 14.865 | 邊際利潤分析 |
| 銷售毛利率 (%) | 26.357 | 23.845 | 25.664 | 23.904 | 26.730 |
| 營業利潤率 (%) | 10.945 | 10.082 | 10.634 | 9.593 | 12.517 |
| 息稅前利潤/營業總收入 (%) | 10.297 | 9.051 | 9.589 | 8.595 | 12.298 |
| 淨利潤/營業總收入 (%) | 9.104 | 8.575 | 9.197 | 9.381 | 10.685 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | 93.279 | 96.641 | 103.197 | 106.358 | 91.460 |
| 價值變動淨收益/利潤總額(%) | 1.855 | -0.842 | -1.802 | -8.162 | 5.990 |
| 營業外收支淨額/利潤總額(%) | -0.438 | -0.730 | -1.287 | 0.044 | -0.474 | 償債能力分析 |
| 流動比率 (X) | 1.469 | 1.426 | 1.327 | 1.291 | 1.530 |
| 速動比率 (X) | 1.170 | 1.102 | 0.996 | 0.992 | 1.199 |
| 資產負債率 (%) | 48.480 | 46.972 | 51.202 | 54.088 | 44.055 |
| 帶息債務/全部投入資本 (%) | 33.904 | 32.022 | 34.817 | 40.543 | 28.673 |
| 股東權益/帶息債務 (%) | 190.779 | 207.175 | 181.084 | 140.879 | 243.917 |
| 股東權益/負債合計 (%) | 106.137 | 112.758 | 95.189 | 84.771 | 126.987 |
| 利息保障倍數 (X) | -17.146 | -9.448 | -10.542 | -8.570 | -76.929 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 63.985 | 51.794 | 52.771 | 53.180 | 50.936 |
| 存貨周轉天數 (天) | 86.490 | 77.531 | 81.988 | 68.455 | 64.175 |
| 備註： | 報價延遲最少15分鐘，資料更新時間為 20/03/2026 16:30 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
